IMUX vs AAPL: Which Stock is Better?
Side-by-side comparison of Immunic Inc and Apple Inc in 2026
IMUX
Immunic Inc
$1.11
AAPL
Apple Inc
$263.58
Key Metrics Comparison
| Metric | IMUX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $153.95M | N/A | IMUX |
| P/E Ratio | N/A | 32.80 | AAPL |
| EPS (TTM) | $N/A | $7.89 | AAPL |
| Revenue Growth | 0.0% | 0.2% | AAPL |
| Gross Margin | 0.0% | 47.3% | AAPL |
Analyze IMUX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMUX or AAPL a better investment?
Comparing IMUX and AAPL: Immunic Inc has a market cap of $153.95M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMUX and AAPL?
IMUX (Immunic Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMUX or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMUX or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.0% for IMUX.
Which company is more profitable: IMUX or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 0.0% for IMUX.
Which is the larger company: IMUX or AAPL?
Immunic Inc (IMUX) is larger with a market cap of $153.95M compared to N/A for AAPL.
Should I buy IMUX or AAPL in 2026?
Both IMUX and AAPL have investment merit. IMUX trades at $1.11 while AAPL trades at $263.58. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMUX and AAPL stock?
Key differences: Market Cap ($153.95M vs N/A), P/E Ratio (N/A vs 32.8x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 47.3%).